Tag

license

AGTC Licenses Promoter Technology to SparingVision SAS

UF startup and UF Innovate | Sid Martin Biotech alum Applied Genetic Technologies Corporation (AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, announced a licensing agreement that provides its proprietary cone-specific promoter technology to SparingVision SAS, a genomic medicine company developing vision-saving treatments for ocular diseases.

Economic Impact

Despite the pandemic, University of Florida researchers conducted record amounts of research in 2020 and companies born of UF research continued to bring billions of dollars and thousands of jobs into the state.
X